Post date September 19, 2023 Experience RayzeBio $358 million IPO The stock is listed on the Nasdaq Global Market
Post date September 14, 2023 Experience Arm $4.87 billion IPO The deal is the largest U.S. IPO since November 2021
Post date August 25, 2023 Experience TRYT ¥55.2 billion IPO The shares are listed on the Tokyo Stock Exchange
Post date July 19, 2023 Experience ODDITY Tech $424 million IPO The shares are listed on the Nasdaq Global Market
Post date July 5, 2023 Experience Vesta $445.6 million U.S. IPO We advised Vesta on its U.S. IPO and NYSE listing
Post date June 29, 2023 Experience Laekna HK$791 million IPO We advised Laekna on its IPO and HKEX listing
Post date June 27, 2023 Experience Noile-Immune Biotech ¥3.1 billion global IPO The shares are listed on the Tokyo Stock Exchange
Post date June 14, 2023 Experience Cutia Therapeutics HK$412.9 million IPO We advised Cutia on its IPO and HKEX listing
Post date May 9, 2023 Experience ACELYRIN $621 million IPO The stock is listed on the Nasdaq Global Select Market